Oracle Blogs

As Oracle’s Executive Director Digital Trials Strategy, David Blackman has responsibility for aligning digital strategies and innovations with Oracle’s developing business needs. Within his role in Oracle’s Health Sciences Global Businesses Unit, David is responsible for creating and developing differentiating technology and business capabilities through development, partnerships and acquisitions that enhance clinical trial research and accelerate bringing drugs to market for our clients. Before joining Oracle in 2021, he served in the Corporate Development and Strategy group at PPD where he had responsibility for PPDs business innovation, leading and incubated cutting-edge business solutions resulting in the investment, development, integration and commercialization of digital and remote clinical trials capabilities. Prior to that David worked at IBM/Lenovo, where he held a number of global technology and business leadership roles. A graduate of the University of Johannesburg in South Africa, he combines his more than 20 years of experience in development, process and technology innovations with his commitment to implementing cutting-edge technologies as a platform that advance innovative technology solutions in clinical trials worldwide. He holds two patents for technology in human factors innovation.